课题基金 / 基金详情

GENETIC RISK FACTORS FOR METABOLIC SYNDROME IN MINORITY POPULATIONS

GENETIC RISK FACTORS FOR METABOLIC SYNDROME IN MINORITY POPULATIONS
少数民族人群代谢综合征的遗传风险因素
批准号:
7313110
负责人:
ERIC P. HOFFMAN
金额:
$26.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2012-09-29

项目摘要

项目成果

ERIC P. HOFFMAN的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Metabolic syndrome, and the associated type 2 diabetes, has become an epidemic in all "westernized" world cultures, with minority populations at the greatest risk. While considered a disease of mid-age, incidence in pediatric populations is rapidly increasing. Current risk estimates by the CDC predict that children bom in 2000 will have a 50% risk of developing type 2 diabetes, with an average loss of 20 yrs of quality adjusted life. The rapid increases are due to inactivity, and easy availability of calorie-rich food, however there are significant genetic contributions to each of the five component risk factors (blood pressure, glycemic index, HDL, LDL, waist circumference). Identification of genetic risk factors are felt to be important both for understanding of the biology of predispositions, and also to enable more personalized interventions to targeted populations. We present preliminary data on identification of the first major metabolic syndrome risk genetic locus. A 15kb haplotype was identified that contains multiple SNPs, each in evolutionary conserved regulatory regions. Haplotype 2 simultaneously alters three regions away from evolutionary conserved ancestral sequence. Testing of 6 subject cohorts, totaling 9,200 individuals, for this haplotype shows that Haplotype 2 confers protection from metabolic syndrome (relative risk RR=0.5 p<0.0001). We have found many additional phenotypes associated with this locus, including muscle strength, bone volume, adiposity, circulating insulin, circulating glucose, and insulin resistance. We have also shown that the component SNPs alter enhancer and represser function differentially in bone, muscle, and fat cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Trial Readiness for Monitoring Muscle Inflammation in Duchenne Muscular Dystrophy
  • 批准号:
    10725465
  • 项目类别:
  • 资助金额:
    $23.74万
  • 财政年份:
    2023
  • 负责人:
    ERIC P. HOFFMAN
  • 依托单位:
Commercialization Readiness Pilot (CRP) to maximize vamorolone international labeling and sales
  • 批准号:
    10200153
  • 项目类别:
  • 资助金额:
    $167.24万
  • 财政年份:
    2016
  • 负责人:
    ERIC P. HOFFMAN
  • 依托单位:
K12 Career Development Program: Omics of Pediatric Lung Diseases in DC
  • 批准号:
    8857246
  • 项目类别:
  • 资助金额:
    $26.89万
  • 财政年份:
    2013
  • 负责人:
    ERIC P. HOFFMAN
  • 依托单位:
K12 Career Development Program: Omics of Pediatric Lung Diseases in DC
  • 批准号:
    8722615
  • 项目类别:
  • 资助金额:
    $26.95万
  • 财政年份:
    2013
  • 负责人:
    ERIC P. HOFFMAN
  • 依托单位: